One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women

Maturitas

Volumn 57, Issue 2, 2007, Pages 171-181

  Samsioe, Göran ^a   Dvorak, Vladimir ^b   Genazzani, Andrea R ^c   Hamann, Bernd ^d   Heikkinen, Jorma ^e   Mueck, Alfred O ^f   Suzin, Jacek ^g   Kawakami, Fernando T ^h   Ferreira, Alberto ^h   Sun, Dongming ^h   Arguinzoniz, Miguel ^h  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Centrum Ambulantni Gynekologie A Primarni Pe e   (Czech Republic)

^c UNIVERSITY OF PISA   (Italy)

^d Praxis für Frauenheilkunde und Geburtshilfe ^*  (Germany)

^e Osteoporoosiklinikka   (Finland)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Endometrial safety; Estradiol; Norethisterone; Transdermal patch

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG SAFETY; DRUG TOLERABILITY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; GASTROINTESTINAL TRACT; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SPOTTING; VAGINA BLEEDING;

ADMINISTRATION, CUTANEOUS; AGED; DRUG THERAPY, COMBINATION; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 34247118368     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.01.001     Document Type: Article

References (28)

1. World Health Organization. Research on the menopause in the 1990s. WHO Tech Rep Ser 1996; No. 866.
2. Stearns V., Ullmer L., Lopez J.F., Smith Y., Isaacs C., and Hayes D. Hot flushes. Lancet 360 (2002) 1851-1861
3. Warren M.P. A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 190 (2004) 1141-1167
4. Lethaby A., Suckling J., Barlow D., Farquhar C., Jepson R., and Roberts H. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 3 (2004)
5. Diamanti-Kandarakis E. Hormone replacement therapy and risk of malignancy. Curr Opin Obstet Gynecol 16 (2004) 73-78
6. Emons G., Huschmand-Nia A., Krauss T., and Hinney B. Hormone replacement therapy and endometrial cancer. Onkologie 27 (2004) 207-210
7. Anderson G.L., Judd H.L., Kaunitz A.M., et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the women's health initiative randomized trial. JAMA 290 (2003) 1739-1748
8. Wells M., Sturdee D.W., Barlow D.H., et al. Effect on endometrium of long-term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. BMJ 325 (2002) 239-242
9. Hill D.A., Weiss N.S., Beresford S.A., et al. Continuous combined hormone replacement therapy and risk of endometrial cancer. Am J Obstet Gynecol 183 (2000) 1456-1461
10. Weiderpass E., Adami H.O., Baron J.A., et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 91 (1999) 1131-1137
11. Mattsson L.A., and Sporrong T. Low dose hormone replacement therapy: clinical efficacy. Minerva Ginecol 55 (2003) 201-207
12. Shoupe D. HRT dosing regimens: continuous versus cyclic-pros and cons. Int J Fertil Womens Med 46 (2001) 7-15
13. Crust M., Gangar K., and Whitehead M. Administration of steroids by skin patches. Res Reprod 21 (1989) 1-2
14. Powers M.S., Schenkel L., Darley P.E., Good W.R., Balestra J.C., and Place V.A. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 152 (1985) 1099-1106
15. Stumpf P.G. Pharmacokinetics of estrogen. Obstet Gynecol 75 (1990) S9-S14
16. Cedars M.I., and Judd H.L. Non-oral routes of estrogen administration (review). Obstet Gynecol Clin North Am 14 (1987) 269-298
17. Van Erpecum K.J., Van Berge Henegouwen G.P., and Verschoor L. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women (review). Gastroenterology 100 (1991) 482-488
18. Stevenson J.C. Optimising delivery systems for HRT. Maturitas 33 Suppl. 1 (1999) S31-S38
19. Rozenbaum H., Birkhauser M., De Nooyer C., et al. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). Tolerability, adhesion and efficacy. Maturitas 25 (1996) 161-173
20. Dallenbach-Hellweg G., and Poulsen H. Atlas of endometrial histopathology. 2nd ed. (1996), Springer, Berlin
21. In: Kurmann R.J. (Ed). Blaustein's pathology of the female genital tract. 4th ed. (1994), Springer Verlag, New York
22. Committee for Proprietary Medicinal Products (CPMP) Guideline. Points to consider on hormone replacement therapy (CPMP/EWP/021), London, UK. November 19, 1997.
23. Committee for Medicinal Products for Human Use (CHMP) Guideline. Guideline on clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women. May 1, 2006. http://tga.health.gov.au/docs/pdf/euguide/emea/002197enrev1.pdf.
24. Brynhildsen J., and Hammar M. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women. Menopause 9 (2002) 137-144
25. Sporrong T., Hellgren M., Samsioe G., and Mattsson L.A. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 95 (1988) 1042-1048
26. Von Holst T., Rakov V., and Kretschmar S. Amenorrhea rate after switch from sequential hormone replacement therapy to continuous combined administration of low dose estradiol and norethisterone acetate. Zentralbl Gynakol 124 (2002) 368-373
27. Feeley K.M., and Wells M. Hormone replacement therapy and the endometrium. J Clin Pathol 54 (2001) 435-440
28. American Cancer Society. Cancer facts and Figures 2004. Atlanta, GA, USA: American Cancer Society Inc., 2004:14 (www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf).